A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC

Trial Profile

A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC

Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 May 2017

At a glance

  • Drugs AAV-hAADC (Primary)
  • Indications Inborn error amino acid metabolic disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 May 2017 Status changed from recruiting to completed.
    • 10 May 2017 Results published in an Agilis Biotherapeutics Media Release
    • 10 May 2017 According to an Agilis Biotherapeutics media release, this trial is performed under the direction of principal investigator Paul Hwu.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top